Literature DB >> 25391007

Outpatient use of systemic antibiotics in Poland: 2004-2008.

Małgorzata Chlabicz, Sławomir Chlabicz, Ludmiła Marcinowicz, Dorota Rogowska-Szadkowska, Barbara Pytel-Krolczuk, Katarzyna Leszczyńska.   

Abstract

OBJECTIVES: The goal of this study was to evaluate the quantity and pattern of outpatient antibiotic use in Poland between 2004 and 2008 and to determine the trends in prescribing practice. To investigate the oral and parenteral outpatient antibiotic use in Poland.
MATERIAL AND METHODS: Data concerning outpatient use of systemic antibiotics between 2004 and 2008 were obtained from Polish National Health Fund databases expressed as the number of defined daily doses (DDD) per 1000 inhabitants per day (DID) according to the international Anatomical Therapeutic Chemical ATC classification system of the World Health Organization (WHO, version 2009).
RESULTS: Total outpatient antibiotic use in Poland varied from the lowest 17.88DID in 2004 to the highest 21.39DID in 2007. Penicillins (J01C) represented the most frequently prescribed antibiotics constituting more than 50% of the total outpatient antibiotic use. The other most popular groups of antibiotics were tetracyclines (J01A), macrolides (J01F). On the fourth and fifth position were cephalosporins (J01D) and quinolones (J01M), respectively. The parenteral antibiotic use did not exceed 1% of the total outpatient antibiotics prescribed with cefuroxime being the most frequently prescribed drug.
CONCLUSIONS: Total outpatient use of antibiotics in Poland in 2004-2008 was comparable to the median European level. The consumption of all antibiotics slightly increased from 2004 to 2007, and decreased in 2008. The most often prescribed antibiotics were penicillins, mainly amoxicillin and amoxicillin with enzyme inhibitor. During the study period the use of the older (narrow-spectrum) antibiotics decreased in favour of the newer (broad-spectrum) antibiotics. The results suggest the discrepancy between national recommendations and choice of antibiotics by physicians.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25391007

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  6 in total

1.  Amoxicillin Utilization Pattern at Governmental Hospitals in Eastern Ethiopia.

Authors:  Tigist Gashaw; Mekonnen Sisay; Tewodros Tesfa; Yohannes Baye; Firehiwot Amare
Journal:  Infect Drug Resist       Date:  2021-01-20       Impact factor: 4.003

2.  Retrospective Assessment of Antibiotics Prescribing at Public Primary Healthcare Facilities in Addis Ababa, Ethiopia.

Authors:  Fikru Worku; Dagmawit Tewahido
Journal:  Interdiscip Perspect Infect Dis       Date:  2018-02-28

3.  Antibiotic consumption and antimicrobial resistance in Poland; findings and implications.

Authors:  Jadwiga Wojkowska-Mach; Tomasz Bochenek; Brian Godman; Amanda Glassman; Amanj Kurdi; Andrzej Pilc; Anna Rozanska; Szymon Skoczyński; Marta Wałaszek
Journal:  Antimicrob Resist Infect Control       Date:  2018-11-15       Impact factor: 4.887

4.  Evaluation of Drug Susceptibility of Microorganisms in Odontogenic Inflammations and Dental Surgery Procedures Performed on an Outpatient Basis.

Authors:  Mateusz Bogacz; Tadeusz Morawiec; Joanna Śmieszek-Wilczewska; Katarzyna Janowska-Bogacz; Anna Bubiłek-Bogacz; Rafał Rój; Karolina Pinocy; Anna Mertas
Journal:  Biomed Res Int       Date:  2019-10-07       Impact factor: 3.246

5.  Impact of chronic kidney disease on long-term outcome of patients with valvular heart defects.

Authors:  Łukasz Kuźma; Jolanta Małyszko; Hanna Bachórzewska-Gajewska; Marta Maria Niwińska; Anna Kurasz; Małgorzata Zalewska-Adamiec; Marcin Kożuch; Sławomir Dobrzycki
Journal:  Int Urol Nephrol       Date:  2020-07-14       Impact factor: 2.370

6.  Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications.

Authors:  Arianit Jakupi; Brian Godman; Antony Martin; Alan Haycox; Indrit Baholli
Journal:  Pharmacoecon Open       Date:  2018-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.